Novir

We are Novir, a cutting-edge biotechnology company committed to revolutionizing the way the world perceives and approaches healthcare. Our journey began in the midst of the 2020 global pandemic with a clear and urgent mission: to make reliable, inexpensive, point-of-care COVID-19 screening tests available to anyone, anywhere. We saw the critical need for immediate results to enable quick action, displacing the expensive lab tests that were fraught with long lead times and capacity issues. Founded by Alexander Kempe, a seasoned healthcare executive, we quickly mobilized a team of experts in healthcare, medicine, operations, and technology. This allowed us to not only address the immediate crisis but also to lay the groundwork for a much broader vision of preventive healthcare.

Our core belief is that healthcare shouldn't start with a diagnosis; it should begin with prevention. We are pioneering what we call the 'pre-care pathway', a fundamental shift from a reactive to a proactive model of health management. We empower individuals and organizations to take charge of their health through innovative services and technologies. Since our inception, we have expanded our services far beyond COVID-19 testing. Today, our portfolio includes comprehensive solutions like lead testing, vaccinations, preventive health screenings, and drug screening services. We serve a diverse range of clients, including public health organizations, educational institutions, employers, and health systems. Our proprietary technology platform, TRACK, is central to our mission, streamlining everything from scheduling and data collection to results reporting. By leveraging advanced data analytics and AI, we aim to provide actionable insights that help manage risk, instill confidence, and ultimately, foster healthier communities. We are dedicated to making healthcare more accessible, affordable, and reliable for everyone, regardless of their location or background.